in 21 patients with leukemia or lymphoma on l-asp with cyclophosphamide-containing regimens , none developed significant igg antibody response , compared with seven of 13 not receiving cyclophosphamide ( p less than 0.001 ) .
C0024299
lymphoma
C0003993
l-asp